Veldhuizen, Gregory Patrick
Röcken, Christoph
Behrens, Hans-Michael
Cifci, Didem
Muti, Hannah Sophie
Yoshikawa, Takaki
Arai, Tomio
Oshima, Takashi
Tan, Patrick
Ebert, Matthias P.
Pearson, Alexander T.
Calderaro, Julien
Grabsch, Heike I.
Kather, Jakob Nikolas http://orcid.org/0000-0002-3730-5348
Funding for this research was provided by:
Bundesministerium für Gesundheit (ZMVI1-2520DAT111)
Deutsche Krebshilfe (70113864)
Bundesministerium für Bildung und Forschung (PEARL, 01KD2104C; CAMINO, 01EO2101; SWAG, 01KD2215A; TRANSFORM LIVER, 031L0312A)
Deutscher Akademischer Austauschdienst (SECAI, 57616814, SECAI, 57616814)
Gemeinsame Bundesausschuss (Transplant.KI, 01VSF21048)
European Union (ODELIA, 101057091; GENIAL, 101096312)
National Institute for Health and Care Research (NIHR, NIHR213331)
Technische Universität Dresden
Article History
Received: 17 March 2023
Accepted: 9 May 2023
First Online: 3 June 2023
Declarations
:
: HIG has received fees for advisory board activities by AstraZeneca and BMS, not related to this study. JNK reports consulting services for Owkin, France, Panakeia, UK and DoMore Diagnostics, Norway and has received honoraria for lectures by MSD, Eisai and Fresenius.